Protests in Delhi after HIV-positive patients allege shortage of life-saving drugs

The protestors are alleging complete unavailability of certain drugs including those for children living with HIV and random shifting to another class of drugs for most of the patients

FPJ Web DeskUpdated: Saturday, August 13, 2022, 09:47 AM IST
article-image
HIV patients protest outside the National AIDS Control Organization's office in Delhi, claiming a shortage of anti-retroviral drugs | ANI

New Delhi: A group of people who are HIV positive have been protesting outside the National AIDS Control Organisation (NACO) office in Delhi for the past 20 days alleging shortage of certain antiretroviral (ARV) drugs even as the government maintains there is no scarcity at the state or national level.

The government recently told Lok Sabha that there is adequate stock of ARV medicines nationally for around 95 per cent of people living with HIV in India.

The protestors are alleging complete unavailability of certain drugs including those for children living with HIV and random shifting to another class of drugs for most of the patients.

They say if the drugs do not become available in the next few weeks, this will lead to serious complications in HIV-affected people.

"Dolutegravir 50 Mg is the backbone of the National AIDS Control Programme and since April the drug is not available at almost all individual antiretroviral therapy (ART) centres across the country. We have written multiple letters to State AIDS Control Society and NACO and health ministry, mentioning the shortage of this life-saving drug but there has been no response. Besides, DTG, another drug TL is also not available," one of the protesters said.

Another protestor alleged that Nevirapine syrup, a drug for children living with HIV, is also not available in most of the centres.

"The government is claiming that there is adequate stock nationally for around 95 per cent of 'People Living with HIV' who are on first and second line ARV regimens in the country. So going by that figure, 5 per cent of 13,88,000 HIV affected individuals are not getting life saving drugs," he said.

Government denies shortage

Health ministry officials said there is no reported stock out for any ARV drugs at the state level and fresh supply orders for procurement of the next lot of several drugs are already placed. Individual ART centres may have this issue at times, but the medicines are immediately relocated from nearby centres, they said.

An official said India is one of the very few countries that provides free antiretroviral medicines for lifelong treatment of more than 14.5 lakh people living with HIV through 680 ART centres under its National AIDS Control Programme (NACP), which is fully funded by the government of India.

The NACO centrally procures ARV medicines according to national guidelines.

There is an adequate stock nationally for around 95 per cent people living with HIV in India who are on first and second line ARV regimens like tablet TLD (Tenofovir+ Lamivudine+ Dolutegravir) and other ARV regimens, the officials said.

"The mainstay of treatment for more than 85 per vent PLHIV is Tablet TLD (a fixed-dose combination of three anti-retroviral drugs, namely, Tenofovir (300 mg)+Lamivudine (300mg) + Dolutegravir (50mg), for which there is sufficient stock nationally to last more than 3 months," the official said.

Tablet Dolutegravir (DTG)-50mg is required for around 50,000 PLHIV who are either on Alternate-1st/2nd or 3rd-line regimens or those with TB co-infection, officials said.

The Central Medical Services Society (CMSS) has been requested to supply the first lot of the drugs at the earliest so as to ensure that before the present stock runs out, the fresh lot of drugs would have been received, the official added.

Prevalence of AIDS in India

The Government of India estimates that about 2.40 million Indians are living with HIV (1.93 ‐3.04 million) with an adult prevalence of 0.31% (according to 2009 data).

Children ( those below 15 years of age) account for 3.5% of all infections, while 83% are the in age group 15-49 years. Of all HIV infections, 39% (930,000) are among women.

About 1.5 million people are on antiretroviral therapy, far lower than the World Health Organization’s “90-90-90 target” – under which 90% of people with HIV are diagnosed, 90% are on ARV treatment, and 90% are no longer infectious.

The Government of India says it aims to end the HIV epidemic by 2030. In 2019, an estimated 58,900 Aids-related deaths were reported in the country.

According to the latest UNAIDS report released last month, India figures among countries which saw some of the most significant reductions in HIV infections even amidst Covid-19 and other crises. The other countries are South Africa, Nigeria and the United Republic of Tanzania.

However, the report said that India saw an 8% decline in providing TB preventive therapy to people living with HIV in 2019 and 2020. The two other countries were South Africa and the United Republic of Tanzania, which saw treatment fall by 30 per cent.

(with inputs from PTI)

(To receive our E-paper on whatsapp daily, please click here. To receive it on Telegram, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

RECENT STORIES

Nagaland: Education department asks schools to take precautions over frequent child lifting cases

Nagaland: Education department asks schools to take precautions over frequent child lifting cases

WATCH: Effigy falls on crowd during Ravan Dahan in Haryana's Yamunanagar, injuries reported

WATCH: Effigy falls on crowd during Ravan Dahan in Haryana's Yamunanagar, injuries reported

Ajmer: Five drown during Durga immersion post puja festivities

Ajmer: Five drown during Durga immersion post puja festivities

PM Modi blows traditional 'Ranshinga', sounds poll bugle in Himachal

PM Modi blows traditional 'Ranshinga', sounds poll bugle in Himachal

'The sudden avalanche has left unforgettable sorrow': survivors narrate Uttarkashi avalanche...

'The sudden avalanche has left unforgettable sorrow': survivors narrate Uttarkashi avalanche...